New Safe Harbor and General Compliance Program Guidance Provides Opportunity for Buyers to Mitigate Litigation and Fraud Risk
Health Law RX
JANUARY 30, 2024
The DOJ Announcement stresses the importance of investing in strong compliance programs for both the buyers and sellers in business transactions. Healthcare companies should engage experienced regulatory counsel to advise about the nuances of each element as they gauge the impact that regulatory compliance may have on deal terms.
Let's personalize your content